Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug – in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Habeprazole, pariprazole and Eraloc. Its PubChem CID is 5029.
Rabeprazole
| CAS No | 117976-89-3 |
|---|---|
| Molecular Formula | C18H21N3O3S |
| Molecular Weight | 359.4 g/mol |
| Synonyms | 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form.
The listed CAS number is 117976-89-3.
The listed molecular formula is C18H21N3O3S.
The listed molecular weight is 359.4 g/mol.
2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole.
The source lists Habeprazole, pariprazole and Eraloc.